What question did this study set out to answer?

To evaluate the clinical utility and sensitivity of plasma transforming growth factor-beta1 (TGF-beta1) compared to serum alpha-fetoprotein (AFP) in detecting small hepatocellular carcinomas.

December 28, 2001CancerOpen Access

Transforming growth factor‐β1 as a useful serologic marker of small hepatocellular carcinoma

View Full Paper

Ask AI

Bookmark

Authors

BSByung‐Cheol SongUlsan College YCYoung–Hwa ChungJeju National University Hospital JKJung A KimChonnam National University

Discussion

Member takes

Implication

Comparative diagnostic study demonstrates superior sensitivity of plasma TGF-beta1 over AFP in small liver tumors, suggesting potential for earlier cancer detection.

Key Points

To evaluate the clinical utility and sensitivity of plasma transforming growth factor-beta1 (TGF-beta1) compared to serum alpha-fetoprotein (AFP) in detecting small hepatocellular carcinomas.
Assessed plasma TGF-beta1 and serum AFP concentrations in 38 patients with small hepatocellular carcinoma (<= 3 cm), 31 patients with liver cirrhosis, and 23 healthy volunteers.
Calculated diagnostic sensitivity and specificity thresholds for both serologic biomarkers at the time of diagnosis.
Plasma TGF-beta1 and serum AFP levels were significantly elevated in patients with small hepatocellular carcinoma compared to those with liver cirrhosis alone.
At cutoff levels yielding >95% specificity (800 pg/mL for TGF-beta1 and 200 ng/mL for AFP), plasma TGF-beta1 achieved a diagnostic sensitivity of 68% compared with 24% for serum AFP.

Cite This Study

Song et al. (2001) studied this question.

synapsesocial.com/papers/6a716525ac440176ef2a140c https://doi.org/10.1002/cncr.10170

View Full Paper

Ask AI

Bookmark

Implication

Comparative diagnostic study demonstrates superior sensitivity of plasma TGF-beta1 over AFP in small liver tumors, suggesting potential for earlier cancer detection.

Transforming growth factor‐β1 as a useful serologic marker of small hepatocellular carcinoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Transforming growth factor‐β1 as a useful serologic marker of small hepatocellular carcinoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider